Skip to main content

Patellofemoral Osteoarthritis

1
Pipeline Programs
5
Companies
4
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
1
Engineered cartilage graftPhase 2
ZKR Orthopedics
ZKR OrthopedicsCA - Kentfield
1 program
LIFT ImplantN/A1 trial
Active Trials
NCT06423300Recruiting245Est. Sep 2031
Stryker
StrykerCA - San Jose
1 program
Patellofemoral arthroplastyN/A1 trial
Active Trials
NCT04772625Active Not Recruiting550Est. Apr 2026
Zimmer Biomet
Zimmer BiometFL - Jacksonville
1 program
nSTRIDE Autologous Protein SolutionN/A1 trial
Active Trials
NCT02610192Completed52Est. Jun 2018
Geistlich Pharma
Geistlich PharmaSwitzerland - Root
1 program
Engineered cartilage graftPHASE_21 trial
Active Trials
NCT06576583Recruiting150Est. Jan 2030

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Geistlich PharmaEngineered cartilage graft
ZKR OrthopedicsLIFT Implant
StrykerPatellofemoral arthroplasty
Zimmer BiometnSTRIDE Autologous Protein Solution

Clinical Trials (4)

Total enrollment: 997 patients across 4 trials

NCT06576583Geistlich PharmaEngineered cartilage graft

Implantation of Engineered Cartilage Grafts for Treatment of Patellofemoral Osteoarthritis Versus Surgical Comparators.

Start: Jul 2025Est. completion: Jan 2030150 patients
Phase 2Recruiting
NCT06423300ZKR OrthopedicsLIFT Implant

Evaluation of the Patellar LIFT System for Subjects With Patellofemoral Cartilage Degeneration

Start: Jun 2024Est. completion: Sep 2031245 patients
N/ARecruiting
NCT04772625StrykerPatellofemoral arthroplasty

Failure Analysis of Patellofemoral Arthroplasty

Start: Jan 2019Est. completion: Apr 2026550 patients
N/AActive Not Recruiting
NCT02610192Zimmer BiometnSTRIDE Autologous Protein Solution

nSTRIDE APS in Females With Primary Patellofemoral Osteoarthritis

Start: Mar 2016Est. completion: Jun 201852 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 997 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.